alzheimersdisease
Researchers from the National University of Singapore have made a groundbreaking discovery about the role of a little-known protein in the brain, which could revolutionize the treatment of Alzheimer’s disease and other neurological conditions. Their study, published inCell Research, reveals that the protein Mfsd7c plays a critical role in managing choline levels in the brain, challenging previous assumptions and offering new therapeutic possibilities. Alzheimer’s disease and other neurological disorders present significant health challenges, particularly as the global population ages. Current ...
PsyPost
Researchers from the National University of Singapore have made a groundbreaking discovery about the role of a little-known protein in the brain, which could revolutionize the treatment of Alzheimer’s disease and other neurological conditions. Their study, published inCell Research, reveals that the protein Mfsd7c plays a critical role in managing choline levels in the brain, challenging previous assumptions and offering new therapeutic possibilities. Alzheimer’s disease and other neurological disorders present significant health challenges, particularly as the global population ages. Current ...
PsyPost (CA)
Researchers from the National University of Singapore have made a groundbreaking discovery about the role of a little-known protein in the brain, which could revolutionize the treatment of Alzheimer’s disease and other neurological conditions. Their study, published inCell Research, reveals that the protein Mfsd7c plays a critical role in managing choline levels in the brain, challenging previous assumptions and offering new therapeutic possibilities. Alzheimer’s disease and other neurological disorders present significant health challenges, particularly as the global population ages. Current ...
PsyPost (UK)
In a recent study published in the journal Alzheimer’s & Dementia, researchers have discovered that the connectivity between the locus coeruleus and the medial temporal lobe can be an early indicator of Alzheimer’s disease-related brain atrophy and cognitive decline. They found that lower connectivity between these brain regions during a novelty task was associated with faster atrophy in regions typically affected by Alzheimer’s disease. The motivation behind the new study stemmed from the need to understand the early mechanisms of Alzheimer’s disease, which is characterized by the accumulatio...
PsyPost (CA)
In a recent study published in the journal Alzheimer’s & Dementia, researchers have discovered that the connectivity between the locus coeruleus and the medial temporal lobe can be an early indicator of Alzheimer’s disease-related brain atrophy and cognitive decline. They found that lower connectivity between these brain regions during a novelty task was associated with faster atrophy in regions typically affected by Alzheimer’s disease. The motivation behind the new study stemmed from the need to understand the early mechanisms of Alzheimer’s disease, which is characterized by the accumulatio...
PsyPost
In a recent study published in the journal Alzheimer’s & Dementia, researchers have discovered that the connectivity between the locus coeruleus and the medial temporal lobe can be an early indicator of Alzheimer’s disease-related brain atrophy and cognitive decline. They found that lower connectivity between these brain regions during a novelty task was associated with faster atrophy in regions typically affected by Alzheimer’s disease. The motivation behind the new study stemmed from the need to understand the early mechanisms of Alzheimer’s disease, which is characterized by the accumulatio...
PsyPost (UK)
A new study sheds light the potential mechanism linking a diet high in saturated fats to Alzheimer’s disease. Researchers have identified specific changes in small RNA molecules, known as microRNAs, that act as markers and regulators of the disease, shedding light on how dietary habits can influence the onset of neurodegenerative conditions. The findings were published in the journal Nutrients. “The results of this study are a step forward in our understanding of this disease and may explain the relationship between obesity, type 2 diabetes and the onset of Alzheimer’s. The findings also offer...
PsyPost
A new study sheds light the potential mechanism linking a diet high in saturated fats to Alzheimer’s disease. Researchers have identified specific changes in small RNA molecules, known as microRNAs, that act as markers and regulators of the disease, shedding light on how dietary habits can influence the onset of neurodegenerative conditions. The findings were published in the journal Nutrients. “The results of this study are a step forward in our understanding of this disease and may explain the relationship between obesity, type 2 diabetes and the onset of Alzheimer’s. The findings also offer...
PsyPost (CA)
A new study sheds light the potential mechanism linking a diet high in saturated fats to Alzheimer’s disease. Researchers have identified specific changes in small RNA molecules, known as microRNAs, that act as markers and regulators of the disease, shedding light on how dietary habits can influence the onset of neurodegenerative conditions. The findings were published in the journal Nutrients. “The results of this study are a step forward in our understanding of this disease and may explain the relationship between obesity, type 2 diabetes and the onset of Alzheimer’s. The findings also offer...
PsyPost (UK)
Recent scientific advancements have shown that a lesser-known compound from the cannabis plant, cannabinol (CBN), may hold promise for treating neurological disorders such as Alzheimer’s and Parkinson’s disease. Researchers at the Salk Institute discovered that not only does CBN protect brain cells from age-related damage, but its chemically modified versions could be even more effective. These findings, detailed in the journal Redox Biology, suggest a new frontier in the treatment of traumatic brain injuries and other neurodegenerative diseases. With the prevalence of neurological disorders r...
PsyPost (CA)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら